CMS Issues Proposed Rule Regarding the Medicaid Drug Rebate Program

Start
On May 26, 2023, CMS published a proposed rule that would implement new policies under the Medicaid Drug Rebate Program (MDRP) to: (1) address situations in which drug manufacturers incorrectly report or misclassify their drugs in the MDRP; (2) enhance the MDRP integrity; and (3) assure consistency and accuracy of drug information reporting (Proposed Rule). These new policies are related to new legislative requirements under the Medicaid Services Investment and Accountability Act of 2019…
By: King & Spalding
Previous Story

Where’s the Money? Options for Commercializing Technology, Part 2: White-Label Arrangements

Next Story

Great Britain and European Union Timelines: What Are the Key Dates for Transition?